Li Shuang, Zhang Haiyang, Wang Xinyi, Qu Yanjun, Duan Jingjing, Liu Rui, Deng Ting, Ning Tao, Zhang Le, Bai Ming, Zhou Likun, Wang Xia, Ge Shaohua, Ying Guoguang, Ba Yi
Department of Gastrointestinal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Huan Hu Xi Road 18, Tianjin, 300060, China.
Tumour Biol. 2016 Nov;37(11):15175-15183. doi: 10.1007/s13277-016-5390-6. Epub 2016 Sep 28.
MicroRNAs (miRNAs) have been reported to be involved in each stage of tumor development in various types of cancers. We have previously showed that miR-16 is downregulated in cancer and acts as a tumor suppressor. Other studies indicated that hepatocyte growth factor (HGF)/c-Met is implicated in proliferation, migration, and other pathophysiological processes. However, little is known about the relationship between miR-16 and HGF/c-Met in gastric cancer (GC). In the present study, we used bioinformatics tools and related experiments to search for miRNAs targeting HGF. Here, we found that miR-16 suppressed HGF protein expression by directly targeting 3'-untranslated region (UTR) of HGF mRNA. Subsequently, it was illustrated the downregulation of miR-16 promotes, while overexpressed of miR-16 significantly inhibits cell proliferation and migration by negatively regulating HGF/c-Met pathway. Moreover, the biological role of HGF in GC cells was determined by using HGF siRNA and HGF-overexpressing plasmid, respectively. To conclude, our results provide a potential target by using miR-16 for the future clinical treatment of GC.
据报道,微小RNA(miRNA)参与了各类癌症肿瘤发展的各个阶段。我们之前已经表明,miR-16在癌症中表达下调,并作为一种肿瘤抑制因子发挥作用。其他研究表明,肝细胞生长因子(HGF)/c-Met与增殖、迁移及其他病理生理过程有关。然而,关于miR-16与胃癌(GC)中HGF/c-Met之间的关系,人们所知甚少。在本研究中,我们使用生物信息学工具和相关实验来寻找靶向HGF的miRNA。在此,我们发现miR-16通过直接靶向HGF mRNA的3'-非翻译区(UTR)来抑制HGF蛋白表达。随后,研究表明miR-16的下调促进,而miR-16的过表达通过负调控HGF/c-Met通路显著抑制细胞增殖和迁移。此外,分别使用HGF siRNA和HGF过表达质粒确定了HGF在GC细胞中的生物学作用。总之,我们的结果为未来GC的临床治疗提供了一个潜在的靶点——miR-16。